According to an SEC filing this month, ProShares is planning to launch 25 new ETFs as soon as they make it through the SEC approval process.

The new funds are leveraged, inverse and inverse-leveraged exchange-traded funds. Below are all the new funds listed in the filing:

Ultra ProShares
Ultra NASDAQ Biotechnology
Ultra Dow Jones Select Biotechnology
Ultra Dow Jones Select Telecommunications


Short ProShares
Short NASDAQ Biotechnology
Short Dow Jones Select Biotechnology
Short Dow Jones Select Telecommunications
Short MSCI Emerging Markets
Short MSCI Japan
Short MSCI EAFE
Short FTSE/Xinhua China 25
UltraShort NASDAQ Biotechnology
UltraShort Dow Jones Select Biotechnology
UltraShort Dow Jones Select Telecommunications
UltraShort MSCI Emerging Markets
UltraShort MSCI Japan
UltraShort MSCI EAFE
UltraShort FTSE/Xinhua China 25


Short Non-Equity ProShares
Short Lehman Brothers 7-10 Year U.S. Treasury
Short Lehman Brothers 20+ Year U.S. Treasury
Short iBoxx $ Liquid Investment Grade
Short iBoxx $ Liquid High Yield
UltraShort Lehman Brothers 7-10 Year U.S. Treasury
UltraShort Lehman Brothers 20+ Year U.S. Treasury
UltraShort iBoxx $ Liquid Investment Grade
UltraShort iBoxx $ Liquid High Yield
 

Stay ahead of the news ... Sign up for our email alerts now
CLICK HERE